These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

576 related items for PubMed ID: 16782734

  • 1. Estimating the cost and health status consequences of treatment with TNF antagonists in patients with psoriatic arthritis.
    Bansback NJ, Ara R, Barkham N, Brennan A, Fraser AD, Conway P, Reynolds A, Emery P.
    Rheumatology (Oxford); 2006 Aug; 45(8):1029-38. PubMed ID: 16782734
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. An economic approach to health care.
    Homik JE, Suarez-Almazor M.
    Best Pract Res Clin Rheumatol; 2004 Apr; 18(2):203-18. PubMed ID: 15121040
    [Abstract] [Full Text] [Related]

  • 5. Etanercept and infliximab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Woolacott N, Bravo Vergel Y, Hawkins N, Kainth A, Khadjesari Z, Misso K, Light K, Asseburg C, Palmer S, Claxton K, Bruce I, Sculpher M, Riemsma R.
    Health Technol Assess; 2006 Sep; 10(31):iii-iv, xiii-xvi, 1-239. PubMed ID: 16948890
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Cost effectiveness of adding leflunomide to a 5-year strategy of conventional disease-modifying antirheumatic drugs in patients with rheumatoid arthritis.
    Maetzel A, Strand V, Tugwell P, Wells G, Bombardier C.
    Arthritis Rheum; 2002 Dec 15; 47(6):655-61. PubMed ID: 12522841
    [Abstract] [Full Text] [Related]

  • 10. [Current aspects of cost effectiveness of TNF-alpha blocking agents in patients with rheumatoid arthritis].
    Merkesdal S, Ruof J.
    Z Rheumatol; 2002 Dec 15; 61 Suppl 2():II/29-32. PubMed ID: 12491120
    [Abstract] [Full Text] [Related]

  • 11. Real-world anti-tumor necrosis factor treatment in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: cost-effectiveness based on number needed to treat to improve health assessment questionnaire.
    Barra L, Pope JE, Payne M.
    J Rheumatol; 2009 Jul 15; 36(7):1421-8. PubMed ID: 19487267
    [Abstract] [Full Text] [Related]

  • 12. Biological therapies in the spondyloarthritides--the current state.
    Braun J, Sieper J.
    Rheumatology (Oxford); 2004 Sep 15; 43(9):1072-84. PubMed ID: 15187239
    [Abstract] [Full Text] [Related]

  • 13. The burden of ankylosing spondylitis and the cost-effectiveness of treatment with infliximab (Remicade).
    Kobelt G, Andlin-Sobocki P, Brophy S, Jönsson L, Calin A, Braun J.
    Rheumatology (Oxford); 2004 Sep 15; 43(9):1158-66. PubMed ID: 15226514
    [Abstract] [Full Text] [Related]

  • 14. Patient reported outcomes in a trial of combination therapy with etanercept and methotrexate for rheumatoid arthritis: the TEMPO trial.
    van der Heijde D, Klareskog L, Singh A, Tornero J, Melo-Gomes J, Codreanu C, Pedersen R, Freundlich B, Fatenejad S.
    Ann Rheum Dis; 2006 Mar 15; 65(3):328-34. PubMed ID: 16079172
    [Abstract] [Full Text] [Related]

  • 15. Patient-reported outcomes in a randomized trial of etanercept in psoriatic arthritis.
    Mease PJ, Woolley JM, Singh A, Tsuji W, Dunn M, Chiou CF.
    J Rheumatol; 2010 Jun 15; 37(6):1221-7. PubMed ID: 20395648
    [Abstract] [Full Text] [Related]

  • 16. Current concepts and new developments in the treatment of psoriatic arthritis.
    Pipitone N, Kingsley GH, Manzo A, Scott DL, Pitzalis C.
    Rheumatology (Oxford); 2003 Oct 15; 42(10):1138-48. PubMed ID: 12810935
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of psoriatic arthritis with TNF alpha-antagonists].
    Antoni C, Manger B.
    Z Rheumatol; 2003 Jun 15; 62(3):235-9. PubMed ID: 12827399
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Economic evaluation of etanercept in the management of chronic plaque psoriasis.
    Lloyd A, Reeves P, Conway P, Reynolds A, Baxter G.
    Br J Dermatol; 2009 Feb 15; 160(2):380-6. PubMed ID: 18808413
    [Abstract] [Full Text] [Related]

  • 20. Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation.
    Rodgers M, Epstein D, Bojke L, Yang H, Craig D, Fonseca T, Myers L, Bruce I, Chalmers R, Bujkiewicz S, Lai M, Cooper N, Abrams K, Spiegelhalter D, Sutton A, Sculpher M, Woolacott N.
    Health Technol Assess; 2011 Feb 15; 15(10):i-xxi, 1-329. PubMed ID: 21333232
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.